Adaptam Therapeutics
PrivateLast Round
Pre Seed
Oct 27, 2025
Total Funding Raised
$3.5M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Adaptam Therapeutics is a biotechnology company that develops first-in-class antibody therapies, including antibody-drug conjugates (ADCs) and bispecific antibodies, for solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Adaptam Therapeutics Comparables
Compare Adaptam Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| LTZ Therapeutics | 82% | |
| Resolute Science | 79% | |
| Palleon Pharmaceuticals | 77% |
Adaptam Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Oct 27, 2025 |
Adaptam Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Criteria Capital Risc | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 23, 2026
Monthly visitors increased 338% MoM, reaching 1.1K.
- Oct 27, 2025
$4M raised with Criteria Capital Risc and criteriabioventures leading.
Adaptam Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Adaptam Therapeutics's valuation, stock price, and market status.
Is Adaptam Therapeutics a public or private company?
Adaptam Therapeutics is a private company.
What is the current stock price of Adaptam Therapeutics?
Adaptam Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Adaptam Therapeutics worth (valuation)?
Valuation information for Adaptam Therapeutics is not publicly available.
Can I buy Adaptam Therapeutics stock?
Adaptam Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Adaptam Therapeutics's last funding round?
Adaptam Therapeutics's most recent funding round was Pre Seed on October 27, 2025.
Who are the main investors in Adaptam Therapeutics?
Key investors in Adaptam Therapeutics include Caixa Capital Risc.
Will Adaptam Therapeutics IPO soon?
No public IPO plans have been announced for Adaptam Therapeutics.
How can I track Adaptam Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Adaptam Therapeutics's secondary market activity and sign up for updates.